Amend the bill in section 8 in §4347 by striking out all of subsection 3 (page 2, lines 3 to 6 in L.D.) and inserting the following:
Amend the bill in section 8 in §4349 in subsection 4 in paragraph A in the first line (page 5, line 18 in L.D.) by striking out the following: " copayment" and inserting the following: ' cost-sharing amount'
Amend the bill in section 8 in §4349 in subsection 4 by striking out all of paragraph C (page 5, lines 22 and 23 in L.D.) and inserting the following:
‘ C. The total amount the pharmacy will be reimbursed for the prescription drug from the pharmacy benefits manager or carrier, including the cost-sharing amount paid by a covered person.’
Amend the bill in section 8 in §4350-A by striking out all of subsection 1 (page 7, lines 30 to 34 in L.D.) and inserting the following:
Amend the bill in section 8 in §4350-B in subsection 2 in the 3rd line (page 8, line 5 in L.D.) by inserting after the following: " of interest" the following: ' , as described in paragraph A or B,'
Amend the bill in section 8 in §4350-B by striking out all of subsection 4 (page 8, lines 16 to 28 in L.D.).
Amend the bill in section 8 in §4350-D by inserting after subsection 4 the following:
Amend the bill by relettering or renumbering any nonconsecutive Part letter or section number to read consecutively.
SUMMARY
This amendment makes the following changes to the bill.
1. It clarifies the provision related to excess payments at the point of sale.
2. It requires that all compensation remitted by or on behalf of a pharmaceutical manufacturer, developer or labeler, directly or indirectly, to a carrier or to a pharmacy benefits manager related to its prescription drug benefit must be remitted directly to the covered person at the point of sale or to the carrier to offset premiums for covered persons.
3. It removes the provision related to prescription drug formularies used by carriers as it is duplicative of other provisions in current law.
4. It clarifies that the definition of "carrier" does not include a multiple-employer welfare arrangement if the multiple-employer welfare arrangement contracts with a 3rd-party administrator to manage and administer health benefits, including benefits for prescription drugs.